Name
Expanding Access to Treatment for Justice-Involved Populations: Lessons Learned from States
Date & Time
Wednesday, April 4, 2018, 2:00 PM - 3:15 PM
Speakers
Benjamin Watts, MBA, Health Services Administrator, Vermont Department of Corrections
Jeffrey Locke, MPP, JD, Program Director, National Governors Association
Jennifer Clarke, Medical Program Director, Rhode Island Department of Corrections
Joann Kang, JD, Lead for Policy and Partnerships, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention
Jeffrey Locke, MPP, JD, Program Director, National Governors Association
Jennifer Clarke, Medical Program Director, Rhode Island Department of Corrections
Joann Kang, JD, Lead for Policy and Partnerships, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention
Description
Moderator: David Tapp, JD, MS, Judge, 28th Judicial Circuit of Kentucky, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,GA Bar,GA POST,NAADAC,NASW,NBCC
According to the National Center on Addiction and Substance Abuse, 65% of the U.S. prison population meets the medical criteria for drug or alcohol addiction, but less than 11% receive treatment for that addiction. As a result of the opioid crisis and the chronic, relapsing nature of opioid use disorder, more prisons and jails are turning to medication assisted treatment (MAT) to help stabilize individuals within the corrections system and ease their transition back into community. States are implementing evidence-based MAT programs along with rehabilitation programs for individuals while incarcerated and improved access to case management and recovery services in the community setting following release.
With support from the Centers for Disease Control and Prevention, the National Governor’s Association (NGA) analyzed different ways states are improving access to opioid use disorder treatment for justice-involved populations to identify innovative strategies to be shared with peer states and other stakeholders. In this session, NGA will discuss the national landscape of treatment programs in corrections and key lessons learned. The session also will feature two innovator states piloting MAT programs in correctional settings, highlighting their promising practices in improving health outcomes and reducing recidivism rates. Discussion topics will include: educating prison staff and addressing stigma regarding MAT; designing protocols for the administration of medications; strengthening networks for follow-up care in the community setting; and connecting individuals with case management and recovery support services.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe the use of medication assisted treatment in state correctional institutions
- Describe supportive programming and services to improve success of medication assisted treatment in correctional institutions.
- Explain how to address challenges to implementing medication assisted treatment programs in correctional institutions.
CE Certified By: AMA,AAFP,ACPE,ANCC,APA,GA Bar,GA POST,NAADAC,NASW,NBCC
According to the National Center on Addiction and Substance Abuse, 65% of the U.S. prison population meets the medical criteria for drug or alcohol addiction, but less than 11% receive treatment for that addiction. As a result of the opioid crisis and the chronic, relapsing nature of opioid use disorder, more prisons and jails are turning to medication assisted treatment (MAT) to help stabilize individuals within the corrections system and ease their transition back into community. States are implementing evidence-based MAT programs along with rehabilitation programs for individuals while incarcerated and improved access to case management and recovery services in the community setting following release.
With support from the Centers for Disease Control and Prevention, the National Governor’s Association (NGA) analyzed different ways states are improving access to opioid use disorder treatment for justice-involved populations to identify innovative strategies to be shared with peer states and other stakeholders. In this session, NGA will discuss the national landscape of treatment programs in corrections and key lessons learned. The session also will feature two innovator states piloting MAT programs in correctional settings, highlighting their promising practices in improving health outcomes and reducing recidivism rates. Discussion topics will include: educating prison staff and addressing stigma regarding MAT; designing protocols for the administration of medications; strengthening networks for follow-up care in the community setting; and connecting individuals with case management and recovery support services.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Describe the use of medication assisted treatment in state correctional institutions
- Describe supportive programming and services to improve success of medication assisted treatment in correctional institutions.
- Explain how to address challenges to implementing medication assisted treatment programs in correctional institutions.
Location Name
Hanover CDE
Full Address
Hyatt Regency Atlanta
265 Peachtree St NE
Atlanta, Georgia 30303
United States
265 Peachtree St NE
Atlanta, Georgia 30303
United States